HFM
TXG icon

Harvest Fund Management’s 10x Genomics TXG Stock Holding History

Harvest Fund Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-177
Closed -$7K – 755
2024
Q1 		$7K Sell
177
-1,001
-85% -$44K ﹤0.01% 600
2023
Q4 		$43K Buy
+1,178
New +$51.3K 0.01% 438
2023
Q3 		– Sell
-700
Closed -$39K – 720
2023
Q2 		$39K Hold
700
– – 0.01% 452
2023
Q1 		$39K Buy
+700
New +$32.7K 0.01% 509
2022
Q1 		– Sell
-43
Closed -$6K – 798
2021
Q4 		$6K Hold
43
– – ﹤0.01% 726
2021
Q3 		$6K Hold
43
– – ﹤0.01% 717
2021
Q2 		$8K Hold
43
– – ﹤0.01% 731
2021
Q1 		$7K Buy
+43
New +$7.43K ﹤0.01% 767
2020
Q4 		– Sell
-532
Closed -$69K – 660
2020
Q3 		$69K Buy
+532
New +$55.8K 0.01% 334

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Harvest Fund Management's TXG Position: Q2 2024 in Review

Harvest Fund Management sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 177 shares — an estimated $7K sold.

Harvest Fund Management first reported a position in TXG in Q3 2020 and held it in 9 quarters. The position peaked at $69K in Q3 2020. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Harvest Fund Management reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Harvest Fund Management sold 177 10x Genomics shares in Q2 2024, an estimated $7K.
  • Harvest Fund Management first reported a position in 10x Genomics in Q3 2020 and held it in 9 quarters.
  • Harvest Fund Management's 10x Genomics position peaked at $69K in Q3 2020.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Harvest Fund Management's 13F filing for Q2 2024, filed 8 Aug 2024.